Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11446337 Bacteriotherapy for clostridium difficile colitis

Patent 11446337 was granted and assigned to Rebiotix on September, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Rebiotix
Rebiotix
0
Date Filed
April 27, 2018
0
Date of Patent
September 20, 2022
0
Patent Applicant
Rebiotix
Rebiotix
0
Patent Application Number
15964228
0
Patent Citations
‌
US Patent 10434124 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10434125 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10434126 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10471107 Microbiota restoration therapy (MRT), compositions and methods of manufacture
0
‌
US Patent 10493111 Microbiota restoration therapy (MRT), compositions and methods of manufacture
0
‌
US Patent 10603341 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10610547 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10624932 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10688137 Microbiota restoration therapy (MRT), compositions and methods of manufacture
0
‌
US Patent 10828340 Microbiota restoration therapy (MRT) compositions and methods of manufacture
•••
Patent Citations Received
‌
US Patent 12102655 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 11944654 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 11986500 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 12083150 Microbiota restoration therapy (MRT), composition and methods of manufacture
0
Patent Inventor Names
Edwin J. Hlavka
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11446337
0
Patent Primary Examiner
‌
David W Berke-Schlessel
0

Find more entities like US Patent 11446337 Bacteriotherapy for clostridium difficile colitis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo